Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity

JCI Insight

Volumn 1, Issue 21, 2016, Pages

  Lofgren, Shane ^a   Hinchcliff, Monique ^b   Carns, Mary ^b   Wood, Tammara ^c   Aren, Kathleen ^b   Arroyo, Esperanza ^b   Cheung, Peggie ^a   Kuo, Alex ^a   Valenzuela, Antonia ^a   Haemel, Anna ^d   Wolters, Paul J ^d   Gordon, Jessica ^e   Spiera, Robert ^e   Assassi, Shervin ^f   Boin, Francesco ^d   Chung, Lorinda ^a,g   Fiorentino, David ^a   Utz, Paul J ^a   Whitfield, Michael L ^c   Khatri, Purvesh ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HOSPITAL FOR SPECIAL SURGERY   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85069272661     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/jci.insight.89073     Document Type: Article

References (30)

1. Desbois AC, Cacoub P. Systemic sclerosis: An update in 2016. Autoimmun Rev. 2016; 15(5):417-426.
2. Volkmann ER, Furst DE. Management of systemic sclerosis-related skin disease: a review of existing and experimental therapeutic approaches. Rheum Dis Clin North Am. 2015; 41(3):399-417.
3. Farina G, Lafyatis D, Lemaire R, Lafyatis R. A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum. 2010; 62(2):580-588.
4. Rice LM, Stifano G, Ziemek J, Lafyatis R. Local skin gene expression reflects both local and systemic skin disease in patients with systemic sclerosis. Rheumatology (Oxford). 2016; 55(2):377-379.
5. Rice LM, et al. A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheumatol. 2015; 67(11):3004-3015.
6. Chung L, et al. Molecular framework for response to imatinib mesylate in systemic sclerosis. Arthritis Rheum. 2009; 60(2):584-591.
7. Gordon JK, et al. Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial. Arthritis Res Ther. 2015; 17:213.
8. Hinchcliff M, et al. Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis. J Invest Dermatol. 2013; 133(8):1979-1989.
9. Chakravarty EF, et al. Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis. Arthritis Res Ther. 2015; 17:159.
10. Pendergrass SA, Lemaire R, Francis IP, Mahoney JM, Lafyatis R, Whitfield ML. Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies. J Invest Dermatol. 2012; 132(5):1363-1373.
11. Milano A, et al. Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One. 2008; 3(7):e2696.
12. Assassi S et al. Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis. Arthritis Rheumatol. 2015; 67(11):3016-3026.
13. Sweeney TE, Haynes WA, Vallania F, Ioannidis JP, Khatri P. Methods to increase reproducibility in differential gene expression via meta-analysis [published online ahead of print September 14, 2016]. Nucleic Acids Res. doi: 10.1093/nar/gkw797.
14. Khatri P, et al. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med. 2013; 210(11):2205-2221.
15. Mazur PK, et al. SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Nature. 2014; 510(7504):283-287.
16. Chen R, et al. A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma. Cancer Res. 2014; 74(10):2892-2902.
17. Sweeney TE, Shidham A, Wong HR, Khatri P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med. 2015; 7(287):287ra71.
18. Sweeney TE, Khatri P. Comprehensive validation of the FAIM3:PLAC8 ratio in time-matched public gene expression data. Am J Respir Crit Care Med. 2015; 192(10):1260-1261.
19. Andres-Terre M, et al. Integrated, multi-cohort analysis identifies conserved transcriptional signatures across multiple respiratory viruses. Immunity. 2015; 43(6):1199-1211.
20. Sweeney TE, Braviak L, Tato CM, Khatri P. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir Med. 2016; 4(3):213-224.
21. Li MD, Burns TC, Morgan AA, Khatri P. Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases. Acta Neuropathol Commun. 2014; 2:93.
22. Mori Y, Chen SJ, Varga J. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts. Arthritis Rheum. 2003; 48(7):1964-1978.
23. Draghici S, et al. A systems biology approach for pathway level analysis. Genome Res. 2007; 17(10):1537-1545.
24. Mahoney JM, et al. Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms. PLoS Comput Biol. 2015; 11(1):e1004005.
25. Ihn H. Scleroderma, fibroblasts, signaling, and excessive extracellular matrix. Curr Rheumatol Rep. 2005; 7(2):156-162.
26. Planque S, et al. Autoantibodies to the epidermal growth factor receptor in systemic sclerosis, lupus, and autoimmune mice. FASEB J. 2003; 17(2):136-143.
27. Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol. 2012; 8(2):e1002375.
28. Ramasamy A, Mondry A, Holmes CC, Altman DG. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med. 2008; 5(9):e184.
29. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995; 57(1):289-300.
30. Fisher RA. Statistical Methods for Research Workers. Edinburgh, Scotland: Oliver & Boyd; 1934